OLK
Olink Holding AB ADRNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$3.24B
P/E Ratio
—
EPS
$-0.27
Beta
0.52
52W High
$0.00
52W Low
$0.00
50-Day MA
$24.51
200-Day MA
$24.02
Dividend Yield
—
Profit Margin
-19.70%
Forward P/E
185.19
PEG Ratio
—
About Olink Holding AB ADR
Olink Holding AB (publ) provides various products and services for academic, government, biopharmaceutical, biotechnology and other institutions focused on life science research. The company is headquartered in Uppsala, Sweden.
Fundamentals
| Revenue (TTM) | $170.89M |
| Gross Profit (TTM) | $94.50M |
| EBITDA | $-43.62M |
| Operating Margin | -86.80% |
| Return on Equity | -7.03% |
| Return on Assets | -6.56% |
| Revenue/Share (TTM) | $1.37 |
| Book Value | $3.71 |
| Price-to-Book | 7.02 |
| Price-to-Sales (TTM) | 18.98 |
| EV/Revenue | 18.49 |
| EV/EBITDA | -136.85 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 4.70% |
| Shares Outstanding | $124.34M |
| Float | $40.95M |
| % Insiders | 66.41% |
| % Institutions | 35.23% |
Data last updated: 4/9/2026